Baseline Mental Health Status and Early Psychiatric Outcomes after Metabolic-Bariatric Surgery: A Retrospective Cohort Study - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Initial Mental Health Conditions and Subsequent Psychiatric Results Following Metabolic-Bariatric Surgery: A Retrospective Cohort Analysis

  • By

  • Patricia M. Ortega

  • Luke Boyle

  • Dana Mahdi

  • Zahra Al-Essah

  • Ali Abdul Hussein

  • Mina Abdul Hussein

  • Aslesha Deshraju

  • Elena Brachimi

  • Prasidha Rai

  • Elsie Ampomah

  • Neha Hussain

  • Faizan Kiani

  • Mary Obigbesan

  • Lucy Tweedlie

  • Samantha Scholtz

  • Sanjay Purkayastha

  • Christos Tsironis

  • Sherif Hakky

  • Ravi Aggarwal

  • Ahmed R. Ahmed

  • Tricia Tan

  • Julia Kenkre

  • Kleopatra Alexiadou

  • Saira Hameed

  • Harvinder Chahal

  • Jonathan Cousins

  • Chioma Izzi-Engbeaya

  • August 29, 2026

Share

  • 1

    Metabolic-bariatric surgery (MBS) is the most effective treatment for severe obesity, leading to significant weight loss and reduced morbidity.

  • 2

    Up to 50% of individuals seeking MBS have co-existing mental health conditions, which may impact postoperative recovery and quality of life.

  • 3

    While depressive and anxiety symptoms often improve in the first year after MBS, long-term follow-up may reveal increased risks of self-harm and suicide.

  • 4

    The study evaluated psychiatric and metabolic outcomes in adults undergoing MBS, focusing on the impact of pre-existing mental health conditions.

  • 5

    Data were collected from a high-volume tertiary MBS unit, with a follow-up period of two years to assess outcomes related to mental health and weight loss.

Original Source(s)

Baseline Mental Health Status and Early Psychiatric Outcomes after Metabolic-Bariatric Surgery: A Retrospective Cohort Study

  • by Patricia M. Ortega, Luke Boyle, Dana Mahdi, Zahra Al-Essah, Ali Abdul Hussein, Mina Abdul Hussein, Aslesha Deshraju, Elena Brachimi, Prasidha Rai, Elsie Ampomah, Neha Hussain, Faizan Kiani, Mary Obigbesan, Lucy Tweedlie, Samantha Scholtz, Sanjay Purkayastha, Christos Tsironis, Sherif Hakky, Ravi Aggarwal, Ahmed R. Ahmed, Tricia Tan, Julia Kenkre, Kleopatra Alexiadou, Saira Hameed, Harvinder Chahal, Jonathan Cousins, Chioma Izzi-Engbeaya

  • August 29, 2026

Related Content

Letter to the Editor: “Organ donation after ECPR: ethical challenges and clinical implications”

FDA monthly preview: Key September decisions to watch

Several FDA decisions across multiple specialties are expected this month.

Patient selection, not age alone, matters when interpreting outcomes of SSRF in older adults